As the clinical trials sector begins to recover from the impacts of the COVID-19 pandemic, Cromos Pharma’s US BD Director, Nicole Brenna, discussed how her interactions with clients have shown the extent to which the industry was affected. She also talked about how the pandemic accelerated adoption of decentralized/virtual trials and other technologies. Finally, she talked about client priorities now as the industry recovers. Read our Q and A here.
This July, Cromos Pharma is highlighting Sarcoma Awareness Month. Sarcomas are rare malignant cancer tumors that start in the bones and soft tissues. The most common type of sarcoma is soft tissue sarcoma. Four out of five sarcomas occur in soft issues. Over half of these are found in the leg but sarcomas can occur in any part of the body.